Skip to content
PubMed This is a summary of 66 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 66 referenced papers

Top Authors

Peter J. Krause
Connecticut Children's Medical Center
Gary P. Wormser
New York Medical College
Choukri Ben Mamoun
Yale University
Edouard Vannier
Tufts Medical Center
Susan L. Stramer
University of the Potomac
Rebecca J. Eisen
Centers for Disease Control and Prevention
Evan M. Bloch
Johns Hopkins University
Carlos E. Suárez
Washington State University
Nikhat Parveen
University of Massachusetts Chan Medical School
John D. Scott
University of California, Davis

Top Institutions

Ranked by publications Top 10 institutions
06

Huazhong Agricultural University

Wuhan, China

17 papers
10

National Center for Emerging and Zoonotic Infectious Diseases

Atlanta, United States

14 papers

References

References (66)
  1. 1

    Fever in a visitor to Canada: a case of mistaken identity.

    Warren T, Lau R, Ralevski F, et al.

    Journal of clinical microbiology 2015; (53(5)):1783-5 doi:10.1128/JCM.00269-15.

    PMID: 25762775
  2. 2

    Utilization of a real-time PCR assay for diagnosis of Babesia microti infection in clinical practice.

    Wang G, Wormser GP, Zhuge J, et al.

    Ticks and tick-borne diseases 2015; (6(3)):376-82.

    PMID: 25819568
  3. 3

    A case of severe babesiosis treated successfully with exchange transfusion.

    Tanyel E, Guler N, Hokelek M, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015; (38()):83-5.

    PMID: 26232090
  4. 4

    Apheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both?

    Saifee NH, Krause PJ, Wu Y

    Journal of clinical apheresis 2016; (31(5)):454-8 doi:10.1002/jca.21429.

    PMID: 26481763
  5. 5

    Persistence of babesiosis for >2 years in a patient on rituximab for rheumatoid arthritis.

    Raffalli J, Wormser GP

    Diagnostic microbiology and infectious disease 2016; (85(2)):231-2.

    PMID: 27036977
  6. 6

    Infection with Babesia microti in humans with non-specific symptoms in North East Poland.

    Moniuszko-Malinowska A, Swiecicka I, Dunaj J, et al.

    Infectious diseases (London, England) 2016; (48(7)):537-43 doi:10.3109/23744235.2016.1164339.

    PMID: 27118086
  7. 7

    Microscopic and Molecular Detection of Camel Piroplasmosis in Gadarif State, Sudan.

    Ibrahim AM, Kadle AA, Nyingilili HS

    Veterinary medicine international 2017; (2017()):9345231 doi:10.1155/2017/9345231.

    PMID: 28293445
  8. 8

    Possible Transfusion-Transmitted Babesia divergens-like/MO-1 Infection in an Arkansas Patient.

    Burgess MJ, Rosenbaum ER, Pritt BS, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017; (64(11)):1622-1625 doi:10.1093/cid/cix216.

    PMID: 28329282
  9. 9

    Autoimmune hemolytic anemia associated with babesiosis.

    Narurkar R, Mamorska-Dyga A, Nelson JC, Liu D

    Biomarker research 2017; (5()):14 doi:10.1186/s40364-017-0095-6.

    PMID: 28405337
  10. 10

    Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia.

    Simon MS, Westblade LF, Dziedziech A, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017; (65(7)):1222-1225 doi:10.1093/cid/cix477.

    PMID: 28541469
  11. 11

    Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis.

    Mareedu N, Schotthoefer AM, Tompkins J, et al.

    The American journal of tropical medicine and hygiene 2017; (97(4)):1218-1225 doi:10.4269/ajtmh.17-0146.

    PMID: 28722598
  12. 12

    First record of locally acquired human babesiosis in Canada caused by Babesia duncani: a case report.

    Scott JD

    SAGE open medical case reports 2017; (5()):2050313X17725645 doi:10.1177/2050313X17725645.

    PMID: 28890784
  13. 13

    Congenital Babesiosis After Maternal Infection With Borrelia burgdorferi and Babesia microti.

    Saetre K, Godhwani N, Maria M, et al.

    Journal of the Pediatric Infectious Diseases Society 2018; (7(1)):e1-e5 doi:10.1093/jpids/pix074.

    PMID: 28992325
  14. 14

    Babesia microti infection and hemophagocytic lymphohistiocytosis in an immunocompetent patient.

    Go SA, Phuoc VH, Eichenberg SE, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2017; (65()):72-74 doi:10.1016/j.ijid.2017.09.026.

    PMID: 28993284
  15. 15

    Tick-borne illness after transplantation: Case and review.

    Mascarenhas TR, Silibovsky RS, Singh P, Belden KA

    Transplant infectious disease : an official journal of the Transplantation Society 2018; (20(2)):e12830 doi:10.1111/tid.12830.

    PMID: 29277955
  16. 16

    Transfusion-transmitted and community-acquired babesiosis in New York, 2004 to 2015.

    Linden JV, Prusinski MA, Crowder LA, et al.

    Transfusion 2018; (58(3)):660-668 doi:10.1111/trf.14476.

    PMID: 29383735
  17. 17

    A pilot serosurvey of Babesia microti in Chinese blood donors.

    Bloch EM, Yang Y, He M, et al.

    Vox sanguinis 2018; (113(4)):345-349 doi:10.1111/vox.12648.

    PMID: 29582438
  18. 18

    Superior real-time polymerase chain reaction detection of Babesia microti parasites in whole blood utilizing high-copy BMN antigens as amplification targets.

    Grabias B, Clement J, Krause PJ, et al.

    Transfusion 2018; (58(8)):1924-1932 doi:10.1111/trf.14642.

    PMID: 29664114
  19. 19

    Investigating disease severity in an animal model of concurrent babesiosis and Lyme disease.

    Bhanot P, Parveen N

    International journal for parasitology 2019; (49(2)):145-151 doi:10.1016/j.ijpara.2018.06.006.

    PMID: 30367867
  20. 20

    Transfusion-Transmitted Babesiosis.

    Villatoro T, Karp JK

    Archives of pathology & laboratory medicine 2019; (143(1)):130-134 doi:10.5858/arpa.2017-0250-RS.

    PMID: 30376376
  21. 21

    High seroprevalence of Babesia antibodies among Borrelia burgdorferi-infected humans in Sweden.

    Svensson J, Hunfeld KP, Persson KEM

    Ticks and tick-borne diseases 2019; (10(1)):186-190 doi:10.1016/j.ttbdis.2018.10.007.

    PMID: 30389326
  22. 22

    Establishment of a continuous in vitro culture of Babesia duncani in human erythrocytes reveals unusually high tolerance to recommended therapies.

    Abraham A, Brasov I, Thekkiniath J, et al.

    The Journal of biological chemistry 2018; (293(52)):19974-19981 doi:10.1074/jbc.AC118.005771.

    PMID: 30463941
  23. 23

    Adjunctive treatment of clinically severe babesiosis with red blood cell exchange: a case series of nineteen patients.

    Nixon CP, Park S, Nixon CE, et al.

    Transfusion 2019; (59(8)):2629-2635 doi:10.1111/trf.15346.

    PMID: 31145479
  24. 24

    Characteristics of transfusion-transmitted Babesia microti, American Red Cross 2010-2017.

    Tonnetti L, Townsend RL, Dodd RY, Stramer SL

    Transfusion 2019; (59(9)):2908-2912 doi:10.1111/trf.15425.

    PMID: 31250463
  25. 25

    A Case of Babesiosis in a Pregnant Patient Treated with Red Blood Cell Exchange Transfusion.

    Abittan B, Nizam A, Oey M, et al.

    Case reports in obstetrics and gynecology 2019; (2019()):9869323 doi:10.1155/2019/9869323.

    PMID: 31275683
  26. 26

    Persistence of Babesia microti Infection in Humans.

    Bloch EM, Kumar S, Krause PJ

    Pathogens (Basel, Switzerland) 2019; (8(3)) doi:10.3390/pathogens8030102.

    PMID: 31319461
  27. 27

    Prevalence of Babesia in Canadian blood donors: June-October 2018.

    Tonnetti L, O'Brien SF, Grégoire Y, et al.

    Transfusion 2019; (59(10)):3171-3176 doi:10.1111/trf.15470.

    PMID: 31385317
  28. 28

    Splenic infarction in babesiosis: A rare presentation.

    Gupta A, Patel P, Manvar K, et al.

    Clinical case reports 2019; (7(8)):1591-1595 doi:10.1002/ccr3.2301.

    PMID: 31428398
  29. 29

    Repeat exchange transfusion for treatment of severe babesiosis.

    Radcliffe C, Krause PJ, Grant M

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2019; (58(5)):638-640 doi:10.1016/j.transci.2019.07.010.

    PMID: 31526674
  30. 30

    Management strategies for human babesiosis.

    Smith RP, Hunfeld KP, Krause PJ

    Expert review of anti-infective therapy 2020; (18(7)):625-636 doi:10.1080/14787210.2020.1752193.

    PMID: 32268823
  31. 31

    Clofazimine, a Promising Drug for the Treatment of Babesia microti Infection in Severely Immunocompromised Hosts.

    Tuvshintulga B, Vannier E, Tayebwa DS, et al.

    The Journal of infectious diseases 2020; (222(6)):1027-1036 doi:10.1093/infdis/jiaa195.

    PMID: 32310272
  32. 32

    A Fluorescence in Situ Hybridization (FISH) Test for Diagnosing Babesiosis.

    Shah JS, Mark O, Caoili E, et al.

    Diagnostics (Basel, Switzerland) 2020; (10(6)) doi:10.3390/diagnostics10060377.

    PMID: 32517217
  33. 33

    Acute Kidney Injury Caused by Evans Syndrome with Systemic Lupus Erythematosus and Systemic Sclerosis.

    Matsuoka N, Watanabe H, Kurooka N, et al.

    Internal medicine (Tokyo, Japan) 2021; (60(7)):1055-1060 doi:10.2169/internalmedicine.5976-20.

    PMID: 33116016
  34. 34

    Parasite burden and red blood cell exchange transfusion for babesiosis.

    O'Bryan J, Gokhale A, Hendrickson JE, Krause PJ

    Journal of clinical apheresis 2021; (36(1)):127-134 doi:10.1002/jca.21853.

    PMID: 33179803
  35. 35

    Babesiosis: Appreciating the Pathophysiology and Diverse Sequela of the Infection.

    Ortiz JF, Millhouse PW, Morillo Cox Á, et al.

    Cureus 2020; (12(10)):e11085 doi:10.7759/cureus.11085.

    PMID: 33224678
  36. 36

    [Clinical characteristics, diagnosis and treatment of human babesiosis: a review].

    Wang F, Jiang JF, Tian J, Du CH

    Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control 2020; (33(2)):218-224 doi:10.16250/j.32.1374.2020168.

    PMID: 34008373
  37. 37

    Documentation of a false positive Lyme disease serologic test in a patient with untreated Babesia microti infection carries implications for accurately determining the frequency of Lyme disease coinfections.

    Wormser GP

    Diagnostic microbiology and infectious disease 2021; (101(1)):115429 doi:10.1016/j.diagmicrobio.2021.115429.

    PMID: 34133997
  38. 38

    Severe babesiosis with associated splenic infarcts and asplenia.

    Sporn ZA, Fenves AZ, Sykes DB, Al-Samkari H

    Proceedings (Baylor University. Medical Center) 2021; (34(5)):597-599 doi:10.1080/08998280.2021.1930632.

    PMID: 34456483
  39. 39

    Babesiosis as a Cause of Atraumatic Splenic Injury: Two Case Reports and a Review of Literature.

    Sung LH, Sundaram AH, Glick AL, et al.

    Journal of general internal medicine 2021; (36(12)):3869-3874 doi:10.1007/s11606-021-07117-5.

    PMID: 34549355
  40. 40

    Spreading of Human Babesiosis in China: Current Epidemiological Status and Future Challenges.

    Chen M, Liu Q, Xue J, et al.

    China CDC weekly 2020; (2(33)):634-637 doi:10.46234/ccdcw2020.176.

    PMID: 34594726
  41. 41

    In Silico Survey and Characterization of Babesia microti Functional and Non-Functional Proteases.

    Florin-Christensen M, Wieser SN, Suarez CE, Schnittger L

    Pathogens (Basel, Switzerland) 2021; (10(11)) doi:10.3390/pathogens10111457.

    PMID: 34832610
  42. 42

    A Five-Week-Old Twin With Profound Anemia: A Case Report of Asymmetric Congenital Babesiosis.

    Walker S, Coray E, Ginsberg-Peltz J, Smith L

    Cureus 2022; (14(3)):e22774 doi:10.7759/cureus.22774.

    PMID: 35382190
  43. 43

    Babesia and Human Babesiosis.

    Montero E, Gray J, Lobo CA, González LM

    Pathogens (Basel, Switzerland) 2022; (11(4)) doi:10.3390/pathogens11040399.

    PMID: 35456074
  44. 44

    Severe Babesiosis With Heavy Parasitemia in an Immunocompetent Patient Treated Successfully With Red Cell Exchange Transfusion.

    Sanivarapu RR, Kashyap V, Iqbal J

    Cureus 2022; (14(3)):e23344 doi:10.7759/cureus.23344.

    PMID: 35475076
  45. 45

    Broad Antimicrobial Resistance in a Case of Relapsing Babesiosis Successfully Treated With Tafenoquine.

    Rogers R, Krause PJ, Norris AM, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023; (76(4)):741-744 doi:10.1093/cid/ciac473.

    PMID: 35684960
  46. 46

    Trust the Process: Prolonged Babesia Parasitemia in an Elderly Man with Asplenia from the American Midwest.

    Ivancich M, Lutwick L, Shweta FNU

    The American journal of case reports 2022; (23()):e936326 doi:10.12659/AJCR.936326.

    PMID: 35844076
  47. 47

    A Case Report and Literature Review of Babesiosis-Induced Acute Respiratory Distress Syndrome.

    Yune PS, Islam I, Dicpinigaitis PV, et al.

    Case reports in infectious diseases 2022; (2022()):4318731 doi:10.1155/2022/4318731.

    PMID: 36411784
  48. 48

    Deployment of a Reservoir-Targeted Vaccine Against Borrelia burgdorferi Reduces the Prevalence of Babesia microti Coinfection in Ixodes scapularis Ticks.

    Vannier E, Richer LM, Dinh DM, et al.

    The Journal of infectious diseases 2023; (227(10)):1127-1131 doi:10.1093/infdis/jiac462.

    PMID: 36416014
  49. 49

    Comparison of high throughput RNA sequences between Babesia bigemina and Babesia bovis revealed consistent differential gene expression that is required for the Babesia life cycle in the vertebrate and invertebrate hosts.

    Capelli-Peixoto J, Saelao P, Johnson WC, et al.

    Frontiers in cellular and infection microbiology 2022; (12()):1093338 doi:10.3389/fcimb.2022.1093338.

    PMID: 36601308
  50. 50

    Babesia microti Causing Intravascular Hemolysis in Immunocompetent Child, China.

    Yao J, Liu G, Zou Y, et al.

    Emerging infectious diseases 2023; (29(3)):667-669 doi:10.3201/eid2903.220888.

    PMID: 36823712
  51. 51

    Relapsing Babesiosis With Molecular Evidence of Resistance to Certain Antimicrobials Commonly Used to Treat Babesia microti Infections.

    Marcos LA, Wormser GP

    Open forum infectious diseases 2023; (10(8)):ofad391 doi:10.1093/ofid/ofad391.

    PMID: 37539067
  52. 52

    Establishment of a stable transfection and gene targeting system in Babesia divergens.

    Cubillos EFG, Snebergerova P, Borsodi S, et al.

    Frontiers in cellular and infection microbiology 2023; (13()):1278041 doi:10.3389/fcimb.2023.1278041.

    PMID: 38156314
  53. 53

    Atovaquone-Proguanil: A Promising Therapy for Persistent Relapsing Babesiosis.

    Shahid M, Wechsler B, Parameswaran V, Diaz MA

    Case reports in infectious diseases 2024; (2024()):7168928 doi:10.1155/2024/7168928.

    PMID: 38774593
  54. 54

    Tafenoquine for Relapsing Babesiosis: A Case Series.

    Krause PJ, Rogers R, Shah MK, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024; (79(1)):130-137 doi:10.1093/cid/ciae238.

    PMID: 38814096
  55. 55

    Autochthonous Human Babesiosis Caused by Babesia venatorum, the Netherlands.

    Spoorenberg N, Köhler CF, Vermeulen E, et al.

    Emerging infectious diseases 2024; (30(9)):1934-1938 doi:10.3201/eid3009.240556.

    PMID: 39174031
  56. 56

    Case Report: Diagnosis of Hemolytic Anemia from Babesia and Secondary Multi-Pathogen Pneumonia Using a Metagenomic Next-Generation Sequencing Approach.

    Lu Y, Zhang D, Han D, et al.

    Infection and drug resistance 2024; (17()):3785-3791 doi:10.2147/IDR.S472861.

    PMID: 39247756
  57. 57

    Beyond Human Babesiosis: Prevalence and Association of Babesia Coinfection with Mortality in the United States, 2015-2022: A Retrospective Cohort Study.

    Ssentongo P, Venugopal N, Zhang Y, et al.

    Open forum infectious diseases 2024; (11(10)):ofae504 doi:10.1093/ofid/ofae504.

    PMID: 39381028
  58. 58

    Transfusion related babesiosis in a non-endemic region (Western New York).

    Aladeen J, Wadhawan P, Pendyala R, et al.

    Oxford medical case reports 2024; (2024(11)):omae133 doi:10.1093/omcr/omae133.

    PMID: 39575087
  59. 59

    Vesicular mechanisms of drug resistance in apicomplexan parasites.

    Haldar K, Bhattacharjee S

    Microbiology and molecular biology reviews : MMBR 2025; (89(1)):e0001024 doi:10.1128/mmbr.00010-24.

    PMID: 39853128
  60. 60

    Emerging babesiosis in the mid-Atlantic: autochthonous human babesiosis cases and Babesia microti (Piroplasmida: Babesiidae) in Ixodes scapularis (Acari: Ixodidae) and Ixodes keiransi (Acari: Ixodidae) ticks from Delaware, Maryland, Virginia, West Virginia, and the District of Columbia, 2009 to 2024.

    Stromdahl EY, Feldman KA, Nadolny RM, et al.

    Journal of medical entomology 2025; (62(4)):995-1008 doi:10.1093/jme/tjaf054.

    PMID: 40261095
  61. 61

    Babesiosis-Induced Hemophagocytic Lymphohistiocytosis Following Spontaneous Splenic Rupture in a Florida Resident: A Case Report.

    Jacob A, Nacer SA, Shah N

    Cureus 2025; (17(5)):e83360 doi:10.7759/cureus.83360.

    PMID: 40452714
  62. 62

    Babesia microti (Babesiidae, Piroplasmida) infection in a Chinese traveler returning from the United States of America.

    Huang XA, Xiang R, Liao RH, et al.

    Infectious diseases of poverty 2025; (14(1)):45 doi:10.1186/s40249-025-01311-x.

    PMID: 40490844
  63. 63

    Severe Babesiosis With Multifactorial Hemolysis and Pulmonary Complications in an Asplenic Patient at a Tertiary Cancer Center.

    Ayana G, Carlson S, Keraga BK, et al.

    Cureus 2025; (17(10)):e94343 doi:10.7759/cureus.94343.

    PMID: 41220440
  64. 64

    A Prospective Cohort Longitudinal Study of Human Acute Babesiosis: Quality of Life and Severity of Symptoms Through 1-Year Follow-up.

    Zamor R, Zhang X, Lamba P, et al.

    Open forum infectious diseases 2025; (12(12)):ofaf668 doi:10.1093/ofid/ofaf668.

    PMID: 41356266
  65. 65

    A Rare Presentation of Babesia-Associated Splenic Infarction in an Immunocompetent Young Male With Mild Parasitemia.

    Anthony JA, Nikolic D, Pepe R, Fraimow H

    Case reports in medicine 2026; (2026()):5210024 doi:10.1155/carm/5210024.

    PMID: 41488487
  66. 66

    Babesia divergens host cell egress is mediated by essential and druggable kinases and proteases.

    Elsworth B, Keroack CD, Rezvani Y, et al.

    Nature microbiology 2026; (11(2)):492-506 doi:10.1038/s41564-025-02238-7.

    PMID: 41593365